Prelude Capital Management, LLC Boston Scientific Corp Transaction History

Prelude Capital Management, LLC

$1.57 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$67.33 - $77.71 $293,356 - $338,582	4,357 New	4,357 $335,000
Q4 2022 Feb 14, 2023	BUY	$39.56 - $47.22 $826,052 - $986,000	20,881 New	20,881 $966,000
Q3 2021 Nov 15, 2021	SELL	$41.23 - $45.88 $1.45 Million - $1.61 Million	-35,151 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$38.58 - $44.24 $1.36 Million - $1.56 Million	35,151 New	35,151 $1.5 Million
Q1 2021 May 17, 2021	SELL	$35.27 - $39.67 $874,519 - $983,617	-24,795 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$33.15 - $41.97 $248,260 - $314,313	7,489 Added 43.27%	24,795 $891,000
Q3 2020 Nov 16, 2020	SELL	$34.44 - $42.23 $1.44 Million - $1.77 Million	-41,933 Reduced 70.79%	17,306 $661,000
Q2 2020 Aug 14, 2020	BUY	$30.19 - $39.11 $1.79 Million - $2.31 Million	59,174 Added 91036.92%	59,239 $2.08 Million
Q1 2020 May 15, 2020	SELL	$25.83 - $45.71 $1.01 Million - $1.79 Million	-39,240 Reduced 99.83%	65 $2,000
Q4 2019 Feb 14, 2020	SELL	$37.87 - $45.37 $65,098 - $77,991	-1,719 Reduced 4.19%	39,305 $1.78 Million
Q3 2019 Nov 14, 2019	BUY	$40.31 - $43.45 $779,917 - $840,670	19,348 Added 89.26%	41,024 $1.67 Million
Q2 2019 Aug 14, 2019	BUY	$34.91 - $42.98 $71,286 - $87,765	2,042 Added 10.4%	21,676 $932,000
Q1 2019 May 15, 2019	SELL	$32.91 - $40.75 $1.09 Million - $1.36 Million	-33,266 Reduced 62.88%	19,634 $754,000
Q4 2018 Feb 14, 2019	BUY	$31.73 - $39.04 $899,799 - $1.11 Million	28,358 Added 115.55%	52,900 $1.87 Million
Q3 2018 Nov 14, 2018	SELL	$32.83 - $38.63 $296,914 - $349,369	-9,044 Reduced 26.93%	24,542 $945,000
Q2 2018 Aug 14, 2018	SELL	$26.84 - $34.32 $1.41 Million - $1.8 Million	-52,549 Reduced 61.01%	33,586 $1.1 Million
Q1 2018 May 15, 2018	BUY	$25.2 - $28.54 $1.3 Million - $1.47 Million	51,534 Added 148.94%	86,135 $2.35 Million
Q4 2017 Feb 14, 2018	SELL	$24.79 - $29.8 $295,967 - $355,782	-11,939 Reduced 25.65%	34,601 $858,000
Q3 2017 Nov 14, 2017	BUY	$26.26 - $29.17 $1.22 Million - $1.36 Million	46,540	46,540 $1.36 Million

Others Institutions Holding BSX

# of Institutions

1,537

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

Vanguard Group Inc Valley Forge, PA

131M
Shares

$11.4 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

126M
Shares

$11 Billion
0.22% of portfolio
State Street Corp Boston, MA

62.8M
Shares

$5.47 Billion
0.22% of portfolio
Primecap Management CO Pasadena, CA

37.8M
Shares

$3.29 Billion
2.37% of portfolio
Wellington Management Group LLP Boston, MA

32.8M
Shares

$2.86 Billion
0.49% of portfolio

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $125B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Account